💊 Get Accurate, Objective, and Timely Intelligence From DrugPatentWatch
Profile for Cellectis S.A. (CLLS)
« Back to company indexCLLS Chatter Timeline
Stock Ticker for CLLS
Most Active Tweeters for CLLS
| User | Tweets |
|---|---|
| @mediasentiment | 9 |
| @investor_feed | 3 |
| @Tickeron | 3 |
| @newsfilterio | 2 |
| @stock_titan | 2 |
Recent Tweets for CLLS
 |
@crisprtalk $CLLS market cap of 180M. Its tough for these non crispr folks. May 27th 2022, 7:05pm |
 |
@mediasentiment $CLLS new alert at https://t.co/A7qrDarJHY #stocks #daytrading #NYSE #NASDAQ #market 143 May 26th 2022, 8:05am |
|
@mediasentiment $CLLS new alert at https://t.co/A7qrDarJHY #stocks #daytrading #NYSE #NASDAQ #market 142 May 26th 2022, 8:05am |
|
@mediasentiment $CLLS new alert at https://t.co/A7qrDarJHY #stocks #daytrading #NYSE #NASDAQ #market 112 May 24th 2022, 8:05am |
 |
@investor_feed $CLLS 6-K Cellectis (23 May, 4:46pm) ? Cellectis’ Annual Shareholders’ General Meeting to be Held… https://t.co/OUhR1K36jU May 23rd 2022, 8:05pm |
 |
@FastestAlert $CLLS Cellectis’ Annual Shareholders’ General Meeting To Be Held on June 28, 2022 Stock News Alerts In Bio May 23rd 2022, 8:05pm |
 |
@newsfilterio Cellectis' Annual Shareholders' General Meeting to be Held on June 28, 2022 $CLLS https://t.co/qOIfbEyzB0 May 23rd 2022, 8:05pm |
 |
@StockNewsBot2 $CLLS Cellectis’ Annual Shareholders’ General Meeting to be Held on June 28, 2022 https://t.co/uglKokWJ8B May 23rd 2022, 8:05pm |
 |
@stock_titan $CLLS Cellectis’ Annual Shareholders’ General Meeting to be Held on June 28, 2022 https://t.co/4qqYQ2vr2d May 23rd 2022, 8:05pm |
 |
@KS_signals $CLLS SEC Filing 6-K filed: [appointed] of the Bylaws, appointed Mr. Donald A. Bergstrom as Observer of the Board o… https://t.co/VjhARo5eSd May 23rd 2022, 12:05pm |
|
@investor_feed $CLLS 6-K Cellectis (23 May, 7:54am) ? Current report (foreign) https://t.co/nShcLjMdD6 #CLLS #6K #Cellectis #News May 23rd 2022, 11:05am |
 |
@Tickeron $CLLS in Uptrend: Stochastic indicator penetrating overbought zone. View odds for this and other indicators:… https://t.co/W90PGCKTb7 May 22nd 2022, 7:05am |
|
@mediasentiment $CLLS new alert at https://t.co/A7qrDarJHY #stocks #daytrading #NYSE #NASDAQ #market 7 May 22nd 2022, 7:05am |
 |
@ChartMill When comparing the current price to the book value of $CLLS, it is valued rather cheaply. https://t.co/1Yg6DcfEhW https://t.co/ywfD5FUDfu May 21st 2022, 11:05pm |
 |
@ReaderInvest $CLLS Why Cellectis' Shares Rose 22.7% This Week https://t.co/nYfXgQuRZq May 21st 2022, 1:05pm |
|
@Tickeron $CLLS's in Uptrend: Moving Average Convergence Divergence (MACD) Histogram just turned positive. View odds for this… https://t.co/hklR6Z2Fb2 May 21st 2022, 2:05am |
 |
@Loreng91044840 $CLLS ~Top analyst price target today ? https://t.co/f0dLbyCNtE May 20th 2022, 12:05pm |
|
@mediasentiment $CLLS new alert at https://t.co/A7qrDarJHY #stocks #daytrading #NYSE #NASDAQ #market 99 May 20th 2022, 8:05am |
|
@mediasentiment $CLLS new alert at https://t.co/A7qrDarJHY #stocks #daytrading #NYSE #NASDAQ #market 240 May 19th 2022, 11:05am |
|
@Tickeron $CLLS in Uptrend: price may ascend as a result of having broken its lower Bollinger Band on May 11, 2022. View odds… https://t.co/j9ZpfwyR1Q May 18th 2022, 9:05pm |
 |
@MarcJacksonLA $CLLS Robert W Baird Upgrades Cellectis To Outperform From Neutral, $10 PT https://t.co/xKruSlBFiq May 18th 2022, 2:05pm |
 |
@vtmtrading Cellectis upgraded to Outperform at Baird on valuation 'backstop' $CLLS May 18th 2022, 10:05am |
 |
@UsMarketNews $CLLS ?upgrade Baird Upgrades Cellectis to Outperform May 18th 2022, 10:05am |
 |
@bthefirsttoknow First out// $CLLS: Baird Upgrades Cellectis to Outperform https://t.co/B9CaNi5G4R May 18th 2022, 10:05am |
|
@vtmtrading Cellectis upgraded to Outperform from Neutral at Baird $CLLS May 18th 2022, 9:05am |
|
@mediasentiment $CLLS new alert at https://t.co/A7qrDarJHY #stocks #daytrading #NYSE #NASDAQ #market 810 May 18th 2022, 5:05am |
 |
@1stOncology #Cellectis Presents Research Data on a Novel #Immune Evasive Universal #CAR #TCell at #ASGCT22 $CLLS https://t.co/BSfFE8dfyi May 17th 2022, 8:05am |
|
@newsfilterio Cellectis Presents Research Data on a Novel Immune-Evasive Universal CAR T-cell at ASGCT $CLLS https://t.co/6ZFXLb6UCK May 16th 2022, 7:05pm |
 |
@biotechradar_eu Cellectis $ALCLS $CLLS Presents Research Data on a Novel Immune-Evasive Universal CAR T-cell at ASGCT https://t.co/uHgdn2DjCd May 16th 2022, 12:05pm |
 |
@PennyStockNews5 $CLLS ? Sentiments: title 0.3182 | summary 0.5994 Pre-Price: 3.22 | Bid: 3.11 | Ask: 3.19 Volume: 140,392 https://t.co/HUsxj22GI1 May 16th 2022, 12:05pm |
|
@investor_feed $CLLS 6-K Cellectis (16 May, 8:15am) ? Cellectis Presents Research Data on a Novel Immune-Evasive Universal CA… https://t.co/SyJpzxmiqT May 16th 2022, 12:05pm |
 |
@quantisnow $CLLS ? SEC Form 6-K filed by Cellectis S.A. https://t.co/S0lSMDJnur 45 seconds delayed. May 16th 2022, 12:05pm |
|
@StockNewsBot2 $CLLS Cellectis Presents Research Data on a Novel Immune-Evasive Universal CAR T-cell at ASGCT https://t.co/mJd5GEs6xO May 16th 2022, 12:05pm |
|
@stock_titan $CLLS Cellectis Presents Research Data on a Novel Immune-Evasive Universal CAR T-cell at ASGCT https://t.co/4SBOgew4o5 May 16th 2022, 12:05pm |
 |
@moshepeled ? $CLLS ?? ? Cellectis Presents Research Data on a Novel Immune-Evasive Universal CAR T-cell at ASGCT ? https://t.co/frsa5ZuMJV May 16th 2022, 12:05pm |
|
@mediasentiment $CLLS new alert at https://t.co/A7qrDarJHY #stocks #daytrading #NYSE #NASDAQ #market 54 May 16th 2022, 9:05am |
|
@mediasentiment $CLLS new alert at https://t.co/A7qrDarJHY #stocks #daytrading #NYSE #NASDAQ #market 8 May 15th 2022, 7:05am |
 |
@TheTradingBlvd Cellectis S.A.'s (CLLS) CEO Andre Choulika on Q1 2022 Results - Earnings Call Transcript $CLLS https://t.co/Zz87Pumwi2 May 13th 2022, 3:05pm |
 |
@SeekingAlpha $CLLS $CMVLF - Cellectis S.A.'s (CLLS) CEO Andre Choulika on Q1 2022 Results - Earnings Call Transcript.… https://t.co/vceCqm3MBd May 13th 2022, 3:05pm |
 |
@SparkNewswire $CLLS Barclays Maintains Overweight on Cellectis, Lowers Price Target to $7 https://t.co/0GhAjSPczF May 13th 2022, 12:05pm |
|
@Tickeron $CLLS enters a Downtrend as Momentum Indicator dropped below the 0 level on April 12, 2022. View odds for this and… https://t.co/Er2G9IwpbL May 13th 2022, 9:05am |
|
@Tickeron This is amazing! What do you think? $CLLS RSI Indicator left the oversold zone. #CellectisSA #stockmarket #stock… https://t.co/VPO0Z8vp9I May 13th 2022, 8:05am |
|
@Tickeron $CLLS reports Earnings today. $CLLS enters a Downtrend as Momentum Indicator dropped below the 0 level on April 12,… https://t.co/g82QvaHTbV May 13th 2022, 2:05am |
|
@newsfilterio Cellectis Provides Business Update and Reports Financial Results for First Quarter 2022 $CLLS https://t.co/q4pusH2371 May 12th 2022, 9:05pm |
|
@KS_signals $CLLS SEC Filing 6-K filed: [appointed] • On February 10, 2022, Bing C. Wang, PhD, MBA, was appointed as Chief Fina… https://t.co/oc0ApzBMrk May 12th 2022, 8:05pm |
|
@mediasentiment $CLLS new alert at https://t.co/A7qrDarJHY #stocks #daytrading #NYSE #NASDAQ #market 1032 May 12th 2022, 8:05pm |
|
@mediasentiment $CLLS new alert at https://t.co/A7qrDarJHY #stocks #daytrading #NYSE #NASDAQ #market 177 May 11th 2022, 8:05am |
|
@stock_titan $CLLS Monthly information on share capital and company voting rights https://t.co/zag5ivoQgW May 10th 2022, 8:05pm |
 |
@algobotnews Cellectis participates in a conference call with JMP Securities $CLLS May 10th 2022, 5:05pm |
 |
@shortablestocks $CLLS is short sale restricted for 2022-05-09. https://t.co/EyglEKty9Y May 9th 2022, 2:05pm |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2022. All rights reserved.